Unsustained response to brentuximab as single agent therapy in a patient with CD30 positive angiosarcoma.

Angiosarcoma (AS) is a rare and often high-grade malignant vascular tumor [1]. They represent below 2% of all soft tissue sarcomas and present in a broad variety of anatomic locations [1,2]. Predis...